Insider Selling: Molina Healthcare (NYSE:MOH) Insider Sells $1,624,560.00 in Stock

Molina Healthcare, Inc (NYSE:MOH – Get Free Report) insider Jeff Barlow sold 8,000 shares of the firm’s stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $203.07, for a total value of $1,624,560.00. Following the completion of the transaction, the insider owned 59,313 shares of the company’s stock, valued at $12,044,690.91. The trade was a 11.88% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Molina Healthcare Stock Performance

MOH opened at $209.37 on Monday. Molina Healthcare, Inc has a 52-week low of $121.06 and a 52-week high of $244.89. The firm has a market capitalization of $10.93 billion, a PE ratio of -218.09, a PEG ratio of 12.35 and a beta of 0.74. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.69 and a current ratio of 1.69. The business’s 50-day simple moving average is $202.56 and its 200 day simple moving average is $185.69.

Molina Healthcare (NYSE:MOH – Get Free Report) last posted its quarterly earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share for the quarter, beating analysts’ consensus estimates of $0.79 by $0.10. The firm had revenue of $11.08 billion during the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. The business’s revenue was down 3.4% compared to the same quarter last year. During the same period last year, the company earned $1.84 earnings per share. As a group, sell-side analysts expect that Molina Healthcare, Inc will post 5.30 earnings per share for the current fiscal year.

Key Stories Impacting Molina Healthcare

Investors following MOH have been watching these stories:

  • Negative Sentiment: Zacks Research lowered its EPS estimates for Q1 2027 to $2.48 from $2.53, Q3 2027 to $2.17 from $2.23, and Q3 2028 to $3.85 from $4.06. The analyst firm maintained a Hold rating; the downward revisions may weigh on sentiment about Molina’s earnings outlook.
  • Negative Sentiment: Three insiders reported selling a combined 10,382 shares for about $2.11 million, reducing their individual holdings by roughly 6% to 12%. These sales may be viewed as a negative signal, though insider transactions alone do not establish a change in the company’s fundamentals. Jeff Barlow SEC filing Richard Schapiro SEC filing Dale Wolf SEC filing

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on MOH shares. Wells Fargo & Company lowered their target price on shares of Molina Healthcare from $235.00 to $220.00 and set an “equal weight” rating on the stock in a report on Tuesday, July 28th. Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, October 24th. Robert W. Baird set a $198.00 price target on shares of Molina Healthcare in a research note on Friday, October 23rd. Jefferies Financial Group reissued a “hold” rating and issued a $220.00 price objective on shares of Molina Healthcare in a research report on Friday, October 23rd. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Molina Healthcare from $220.00 to $225.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 27th. Three analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $213.88.

Get Our Latest Stock Report on MOH

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Fortitude Family Office LLC boosted its position in Molina Healthcare by 63.7% during the third quarter. Fortitude Family Office LLC now owns 131 shares of the company’s stock worth $25,000 after purchasing an additional 51 shares during the period. Elevation Wealth Partners LLC increased its holdings in shares of Molina Healthcare by 118.2% in the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock valued at $33,000 after purchasing an additional 78 shares during the last quarter. Global Retirement Partners LLC bought a new position in shares of Molina Healthcare in the second quarter valued at about $39,000. Versant Capital Management Inc raised its position in shares of Molina Healthcare by 341.6% in the second quarter. Versant Capital Management Inc now owns 340 shares of the company’s stock valued at $78,000 after purchasing an additional 263 shares during the period. Finally, Contravisory Investment Management Inc. bought a new position in shares of Molina Healthcare in the second quarter valued at about $89,000. 98.50% of the stock is owned by institutional investors and hedge funds.

About Molina Healthcare

(Get Free Report)

Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.

Recommended Stories

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.